On January 1, 2018 the Department of Transportation (DOT) issued a new rule altering the DOT 5 panel urine test. Employers and individuals should be aware that the current DOT drug test is still a urine drug test, collected by qualified collectors, analyzed at a SAMHSA certified laboratory and reviewed by a licensed MRO.
DOT 5 panel urine test includes the following:
- Marijuana (THC)
- Cocaine
- Amphetamines
- Opioids**
- Phencyclidine (PCP)
** Special note: ‘Opioids’ was previously called ‘Opiates’ and all DOT drug tests will continue to include confirmation testing for Codeine, Morphine, and 6-AM (heroin) when necessary.
In the January rule change, the Department of Transportation (DOT) also added initial screening and confirmation testing for the semi-synthetic opioids Hydrocodone, Hydromorphone, Oxycodone, and Oxymorphone to this Opioids group
